# Sodium Hyaluronate Ophthalmic Solution, 0.18% for Treatment of Dry Eye Syndrome

> **NCT01382225** · PHASE3 · COMPLETED · sponsor: **Alcon Research** · enrollment: 1936 (actual)

## Conditions studied

- Dry Eye Syndrome

## Interventions

- **DRUG:** Sodium Hyaluronate Ophthalmic Solution, 0.18%
- **OTHER:** Vehicle

## Key facts

- **NCT ID:** NCT01382225
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 1936 (ACTUAL)
- **Last updated:** 2013-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01382225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01382225, "Sodium Hyaluronate Ophthalmic Solution, 0.18% for Treatment of Dry Eye Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01382225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*